Navigation Links
Funding for animal testing alternative
Date:8/23/2013

A researcher from Plymouth University Peninsula Schools of Medicine and Dentistry has received an award of 94,365 (Sterling) from the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), for a pilot study to develop the lab-based creation of a type of mouse cell which could be used in place of the live animals for research related to infectious and allergic lung conditions.

Macrophages are crucial components of the immune system and play key roles in the body's defence against invading pathogens. Macrophages can be switched to perform different functions by chemical messengers produced by cells and tissues in response to infection. Some are switched to M2 macrophages which play a role in infections and allergic diseases such as asthma.

More needs to be understood about M2 macrophages if they are to play a part in effective therapies for infections. However, the cells acquired from live mice have a limited lifespan and require the repeated use of the animals.

Dr. Gyorgy Fejer will use the award to establish permanently growing, alternatively activated M2 macrophage cell lines in order to reduce the number of animals currently used to provide such cells for study. His work revolves around mouse lung macrophages which can be grown indefinitely and are available in practically unlimited numbers.

Compared with cell harvesting from a live mouse, the difference is striking: approximately 300,000 cells can be obtained from a mouse, whereas Dr. Fejer and his team can obtain 20-30 million cells from a single tissue culture flask.

This means that scientists who research asthma and pulmonary virus and bacterial infections can for the first time have access to almost limitless cells for study, without the need for live mice.

Dr. Fejer's award is one of several presented to scientists across the UK by NC3Rs for smart approaches to reduce animal use in science. It follows the publ
'/>"/>

Contact: Andrew Gould
andrew.gould@plymouth.ac.uk
University of Plymouth
Source:Eurekalert

Page: 1 2

Related biology news :

1. Research!America says budget negotiations heighten urgency to protect research funding
2. Research!America says house funding levels for FY13 could undermine medical progress
3. Mainz University Medical Center attracts funding of Alexander von Humboldt Professorship
4. University of Tennessee professor receives funding for clean coal research
5. House funding bill will delay research progress and place new burdens on NIH
6. Space research institute awards funding to promising medical products
7. University of Minnesota receives $13.1 million in DOE funding for 2 new nationwide centers
8. 2 pioneering plant genomics efforts given a funding boost by National Science Foundation
9. State stem cell research funding agency awards $37.3 million to aid UC Irvine efforts
10. University spin-out company shares in £7.9 million marine energy funding boost
11. £12 million funding to tackle devastating livestock and poultry viruses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2015)... Feb. 12, 2015   MedNet Solutions , ... clinical study management systems, has recently bolstered its ... distinguishing iMedNet as the ... (CROs) and healthcare consultants.  Building on the Program,s ... referrals and numerous co-marketing opportunities), MedNet,s new and ...
(Date:2/11/2015)... 2015 According to ... Market by Product (Cards and Readers, Biometrics, Controllers, Management ... Industrial, Healthcare, Education) and By Geography - Global Forecast and Analysis ... Access Control Market is expected to reach ... CAGR of 10.6% between 2014 and 2020. ...
(Date:2/9/2015)... 9, 2015  Lintec of America recently announced an ... nanotube (CNT) macrostructures, including sheets, yarns and ribbons, developed ... Leveraging the vast industrial resources of the global ... , Lintec of America is forming the Nano-Science and ... , focusing on scaling up the manufacturing and commercialization ...
Breaking Biology News(10 mins):MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
... known as marine protected areas provide many direct benefits ... zones appear to offer limited help to corals in ... study. To protect coral reefs from climate change, ... that can meaningfully reduce greenhouse gas emissions, researchers said. ...
...  AnaptysBio, Inc., a privately held therapeutic antibody company, today ... Michael Gallatin, Ph.D. to the company,s Therapeutic Advisory Board ... members of AnaptysBio,s TAB, Jan de Vries, Ph.D. and ... http://photos.prnewswire.com/prnh/20111205/SF16052LOGO ) AnaptysBio,s TAB is constituted to ...
... and Stanford University are expanding EteRNA a unique research ... that are then tested in a laboratory thanks to ... additions already implemented is a new puzzle in which players ... the presence of other molecules. , A $1 million grant ...
Cached Biology News:Rising ocean temperatures harm protected coral reefs 2Rising ocean temperatures harm protected coral reefs 3AnaptysBio Adds Dr. David L. Lacey and Dr. Michael Gallatin to Therapeutic Advisory Board 2AnaptysBio Adds Dr. David L. Lacey and Dr. Michael Gallatin to Therapeutic Advisory Board 3AnaptysBio Adds Dr. David L. Lacey and Dr. Michael Gallatin to Therapeutic Advisory Board 4Keck award enables Carnegie Mellon and Stanford to dramatically expand crowdsourced RNA design 2
(Date:2/27/2015)... Scotia (PRWEB) February 27, 2015 ... vaccine and immunotherapy company, today announced that the ... application for Fast Track designation and Phase I ... in conjunction with the mutual co-development agreement signed ... obtained Fast Track designation for the DPX-Survivac. , ...
(Date:2/27/2015)... San Francisco, CA (PRWEB) February 27, 2015 ... is joining forces on February 28 with patients and ... to raise awareness for Rare Disease Day®. Rare ... rare diseases and calling attention to the special challenges ... community around them. , “Cytokinetics is proud to stand ...
(Date:2/26/2015)... Calif. , Feb. 26, 2015  23andMe, the ... Kate Black as Privacy Officer and Corporate ... and state privacy laws as well as health care ... team, she will be responsible for reviewing, updating and ... in the U.S. and abroad. She joined the company ...
(Date:2/26/2015)... Fla. , Feb. 26, 2015 DuPont ... growth priorities driven by key research advancements and product ... at today,s Bank of America Merrill Lynch 2015 Global ... the challenge of building grain supplies the last two ... continue at the pace of the last decade, when ...
Breaking Biology Technology:Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 623andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 3DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 4DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 5
... THE WOODLANDS, Texas, Sept. 9 Lexicon Pharmaceuticals, ... company focused on discovering breakthrough treatments for human disease, ... president and chief executive officer, will present at the ... 16, 2010 at 9:10 a.m. Eastern Time. ...
... Chopra, the nation,s first Chief Technology Officer, will deliver ... Tuesday, November 9, summit organizers announced today. Chopra is ... in the White House Office of Science and Technology ... Foundation for the National Institutes of Health in partnership ...
... (Nasdaq: KNDL ), a leading, global full-service clinical ... upcoming Robert W. Baird & Co. 2010 Health Care Conference ... in New York City. Kendle,s formal presentation will ... Chief Operating Officer and Keith Cheesman, Senior Vice President and ...
Cached Biology Technology:Lexicon to Present at Stifel Nicolaus Healthcare Conference 2Aneesh Chopra Joins 2010 mHealth Summit as Keynote Speaker 2Kendle to Present at Robert W. Baird & Co. 2010 Health Care Conference 2
Chemically Defined Lipid Concentrate...
... are membrane-filtered isotonic and enzyme-free aqueous ... cell-conditioning agents in either Ca2+- and ... Ca2+- and Mg2+-free phosphate-buffered saline ... from support substrates and each other ...
... Blocking Reagent , 2 x 50 ml 10X TBST ... 0.2 ml BL21 glycerol stock , 0.2 ml ... , 1010 pfu T7Select Positive Control Lysate , ... S-protein HRP Conjugate , 2 ml T7Select S-protein , ...
... WesternBreeze Immunodetection Kits are designed ... immobilized on nitrocellulose or PVDF membranes. ... (except membranes and primary antibodies), the ... both optimizing your protocol and getting ...
Biology Products: